Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China
在中国某试点城市，无创产前检测作为21三体综合征、18三体综合征、13三体综合征和性染色体非整倍体的一线筛查手段，其临床表现令人满意。
期刊:Human Genomics
影响因子:4.3
doi:10.1186/s40246-020-00268-2
Liu, Yanhui; Liu, Hailiang; He, Yi; Xu, Wanfang; Ma, Qiulin; He, Yuzhen; Lei, Wei; Chen, Guoquan; He, Zheng; Huang, Jiayi; Liu, Jianan; Liu, Yuanru; Huang, Quanfei; Yu, Fubing
